Loading clinical trials...
Loading clinical trials...
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
TransMedics
NCT05732779 · Heart Transplant Rejection, Immune Suppression, and more
NCT07359690 · Heart Transplantation, Dilated Cardiomyopathy (DCM), and more
NCT07291258 · Solid Organ Transplantation, Pregnancy, and more
NCT05025774 · Chronic Lung Disease, Chronic Obstructive Pulmonary Disease, and more
NCT07195032 · Heart Transplant Infection Prevention
University of California San Diago
La Jolla, California
Stanford University
Palo Alto, California
Yale New Haven Hospital
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions